Candriam S.C.A. trimmed its stake in shares of United Therapeutics Corporation (NASDAQ:UTHR – Free Report) by 50.4% in the first quarter, Holdings Channel.com reports. The fund owned 63,066 shares of the biotechnology company’s stock after selling 64,149 shares during the period. Candriam S.C.A.’s holdings in United Therapeutics were worth $37,397,000 at the end of the […]

SG Americas Securities LLC lessened its position in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Free Report) by 86.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,163 shares of the company’s stock after selling 19,530 shares during the period. SG Americas Securities LLC’s […]